Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway

Hydroxysafflor Yellow A (HSYA) may reduce ischemia/reperfusion (I/R) injury. However, the underlying molecular mechanisms remain unclear. The present study explored the effect and the mechanisms of HSYA on myocardial injury in vivo and in vitro. Myocardial infarct size was assessed by Evans blue/2,3...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Donglai, Ding, Tingting, Ni, Bin, Jing, Yunyan, Liu, Shanxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605301/
https://www.ncbi.nlm.nih.gov/pubmed/31173173
http://dx.doi.org/10.3892/ijmm.2019.4230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605301/
https://www.ncbi.nlm.nih.gov/pubmed/31173173
http://dx.doi.org/10.3892/ijmm.2019.4230

Ejemplares similares